Professor Edwin Cuppen describes the work being done by the team that he leads at the Hartwig Medical Foundation. As part of the Center for Personalized Cancer Treatment, this ambitious project has set out to improve personalized cancer treatment in the Netherlands. Prof. Cuppen outlines the framework of the project, the whole genome sequencing workflow and their progress to-date (as of May 2016 when this presentation was filmed at Illumina’s Genomics in Oncology Summit.)
Speaker: Prof. Edwin Cuppen, Director Hartwig Medical Foundation and Professor of Human Genetics UMC Utrecht, The Netherlands
Learn more about Genomics in Oncology, visit our here.
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015.
Subscribe to the Illumina video channel